These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16456764)

  • 1. [Branched chain amino acids as oral supplements in liver cirrhosis].
    Plauth M
    Z Gastroenterol; 2006 Feb; 44(2):207-8. PubMed ID: 16456764
    [No Abstract]   [Full Text] [Related]  

  • 2. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?
    Charlton M
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):72-3. PubMed ID: 16456570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral administration of branched-chain amino acids in the treatment of hepatic disease].
    Qian SC
    Zhonghua Yi Xue Za Zhi; 1986 Sep; 66(9):525-7, 574. PubMed ID: 3098373
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic and clinical effects of the acute and chronic oral administration of a combination of branched-chain amino acids and saccharose].
    Dioguardi FS; Incerti Caselli PL; Abbiati R; Brigatti M; Dell'Oca M; Salerno F
    Minerva Chir; 1983 Nov; 38(21):1815-9. PubMed ID: 6669290
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of branched-chain amino acid-enriched nutrient mixture on natural killer cell activity in viral cirrhosis.
    Takegoshi K; Nanasawa H; Itoh H; Yasuyama T; Ohmoto Y; Sugiyama K
    Arzneimittelforschung; 1998 Jun; 48(6):701-6. PubMed ID: 9689432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
    Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
    Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein catabolism and malnutrition in liver cirrhosis - impact of oral nutritional therapy].
    Norman K; Valentini L; Lochs H; Pirlich M
    Z Gastroenterol; 2010 Jul; 48(7):763-70. PubMed ID: 20607635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
    Kawamura E; Habu D; Morikawa H; Enomoto M; Kawabe J; Tamori A; Sakaguchi H; Saeki S; Kawada N; Shiomi S
    Liver Transpl; 2009 Jul; 15(7):790-7. PubMed ID: 19562716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of branched-chain amino acids in liver disease: the evidence for and against.
    Khanna S; Gopalan S
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):297-303. PubMed ID: 17414498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-energy malnutrition in liver cirrhosis.
    Moriwaki H
    J Gastroenterol; 2002; 37(7):578-9. PubMed ID: 12162420
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver diseases and nutritional therapy].
    Muto Y
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1556-64. PubMed ID: 9410960
    [No Abstract]   [Full Text] [Related]  

  • 16. Do branched chain amino acids improve hepatic encephalopathy in cirrhosis?
    Vergara M; Castro-Gutiérrez V; Rada G
    Medwave; 2016 Dec; 16(Suppl5):e6795. PubMed ID: 28024140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dietary supplements on the Fischer ratio before and after pulmonary rehabilitation.
    Kubo H; Honda N; Tsuji F; Iwanaga T; Muraki M; Tohda Y
    Asia Pac J Clin Nutr; 2006; 15(4):551-5. PubMed ID: 17077074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of hepatic encephalopathy by perfusion of a solution of branched-chain amino acids in the surgical cirrhotic patient].
    Sonnenfeld H; Scherpereel P; Vankemmel M; Cecat P; Verkindre AM; Leroy B
    LARC Med; 1982 Nov; 2(10):875-81. PubMed ID: 7166994
    [No Abstract]   [Full Text] [Related]  

  • 19. [Branched-chain amino acids for parenteral feeding in hepatic failure].
    Kábrt J; Masek Z; Svacina S; Pacovský V; Kruf M; Koubková H
    Sb Lek; 1988 Jul; 90(7):206-12. PubMed ID: 3146806
    [No Abstract]   [Full Text] [Related]  

  • 20. [Amino acid metabolism in liver cirrhosis].
    Ukida M; Takao T
    Nihon Rinsho; 1992 Jul; 50(7):1604-8. PubMed ID: 1404891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.